Connection

Daniel Judge to Myocardium

Back to Details
This is a "connection" page, showing publications Daniel Judge has written about Myocardium.
Daniel Judge
Connection Strength
1.270
Myocardium
  1. Baseline Characteristics Predict the Presence of Amyloid on Endomyocardial Biopsy. J Card Fail. 2017 Apr; 23(4):340-344.
    View in: PubMed
    Score: 0.366
  2. PLEKHM2 Loss-of-Function Is Associated With Dilated Cardiomyopathy. Circ Genom Precis Med. 2022 08; 15(4):e003594.
    View in: PubMed
    Score: 0.134
  3. Ankyrin-B dysfunction predisposes to arrhythmogenic cardiomyopathy and is amenable to therapy. J Clin Invest. 2019 07 02; 129(8):3171-3184.
    View in: PubMed
    Score: 0.109
  4. Tafamidis in transthyretin amyloid cardiomyopathy: effects on transthyretin stabilization and clinical outcomes. Circ Heart Fail. 2015 May; 8(3):519-26.
    View in: PubMed
    Score: 0.081
  5. Cardiac findings and events observed in an open-label clinical trial of tafamidis in patients with non-Val30Met and non-Val122Ile hereditary transthyretin amyloidosis. J Cardiovasc Transl Res. 2015 Mar; 8(2):117-27.
    View in: PubMed
    Score: 0.081
  6. Arrhythmogenic right ventricular dysplasia/cardiomyopathy and cardiac sarcoidosis: distinguishing features when the diagnosis is unclear. Circ Arrhythm Electrophysiol. 2014 Apr; 7(2):230-6.
    View in: PubMed
    Score: 0.075
  7. The variable natural history of idiopathic dilated cardiomyopathy. Isr Med Assoc J. 2012 Nov; 14(11):666-71.
    View in: PubMed
    Score: 0.069
  8. The diagnosis of hypertrophic cardiomyopathy by cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2012 Feb 20; 14:17.
    View in: PubMed
    Score: 0.065
  9. Mechanisms of disease: molecular genetics of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Nat Clin Pract Cardiovasc Med. 2008 May; 5(5):258-67.
    View in: PubMed
    Score: 0.050
  10. Intracardiac giant cells after left ventricular assist device placement. J Heart Lung Transplant. 2007 Apr; 26(4):417-20.
    View in: PubMed
    Score: 0.047
  11. Endomyocardial Biopsy Characterization of Heart?Failure With Preserved Ejection?Fraction and Prevalence of Cardiac Amyloidosis. JACC Heart Fail. 2020 09; 8(9):712-724.
    View in: PubMed
    Score: 0.029
  12. Tnni3k alleles influence ventricular mononuclear diploid cardiomyocyte frequency. PLoS Genet. 2019 10; 15(10):e1008354.
    View in: PubMed
    Score: 0.028
  13. Therapeutic Modulation of the Immune Response in Arrhythmogenic Cardiomyopathy. Circulation. 2019 10 29; 140(18):1491-1505.
    View in: PubMed
    Score: 0.028
  14. Seven factors predict a delayed diagnosis of cardiac amyloidosis. Amyloid. 2018 Sep; 25(3):174-179.
    View in: PubMed
    Score: 0.026
  15. No major role for rare plectin variants in arrhythmogenic right ventricular cardiomyopathy. PLoS One. 2018; 13(8):e0203078.
    View in: PubMed
    Score: 0.026
  16. Lack of Relationship Between Serum Cardiac Troponin I Level and Giant Cell Myocarditis Diagnosis and Outcomes. J Card Fail. 2016 07; 22(7):583-5.
    View in: PubMed
    Score: 0.021
  17. Optimization of Serum Immunoglobulin Free Light Chain Analysis for Subclassification of Cardiac Amyloidosis. J Cardiovasc Transl Res. 2015 Jun; 8(4):264-8.
    View in: PubMed
    Score: 0.020
  18. The change in B-type natriuretic peptide levels over time predicts significant rejection in cardiac transplant recipients. J Heart Lung Transplant. 2009 Jul; 28(7):704-9.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.